Clinical Trials

Neoplasms

NCT00446225 2025-03-05

EURTAC

Phase 3 Completed

174 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00708448 2025-02-13

Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients

Phase 1 Completed

26 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT03192501 2024-06-25

iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray

Recruiting

250 enrolled

Lung Neoplasms, Neoplasms

NCT02925234 2024-01-24

DRUP

Phase 2 Recruiting

1,550 enrolled

Neoplasms

NCT05904457 2023-06-15

BRISK

32 enrolled

Neoplasm Metastasis, Neoplasms

NCT03239015 2022-03-04

Efficacy and Safety of Precision Therapy in Refractory Tumor

300 enrolled

Neoplasms

NCT01636908 2021-04-15

ICK

Phase NA Completed

43 enrolled

Neoplasms

NCT02714530 2021-03-30

ThoRaT

118 enrolled

Neoplasms

NCT02239952 2020-10-08

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Phase NA Unknown

15 enrolled

CNS

Glioma, Neoplasms

NCT00497224 2019-05-30

Phase II Trial of Erlotinib in Advanced Pancreatic Cancer

51 enrolled

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT02889692 2019-04-11

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Phase 3 Completed

23 enrolled

Lung Neoplasms, Neoplasms

NCT01518621 2019-03-13

RadEr

25 enrolled

Neoplasms

NCT03389256 2018-01-03

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

144 enrolled

Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT00369512 2017-05-30

RAD0503

15 enrolled 9 charts

Carcinoma, Squamous Cell, Neoplasms

NCT00841035 2017-05-19

7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients

6 enrolled 3 charts

Neoplasms, Pancreatic Neoplasms

NCT00491816 2017-01-19

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

32 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT02015728 2016-12-15

SEED

Phase NA Unknown

20 enrolled

Neoplasms, Recurrence

NCT00336700 2016-09-19

A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer

25 enrolled 10 charts

Neoplasms, Pancreatic Neoplasms

NCT00585377 2015-09-24

Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer

50 enrolled 7 charts

Neoplasms

NCT00642746 2014-09-26

Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)

16 enrolled 9 charts

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT01565538 2014-09-15

Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma

123 enrolled 9 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00418704 2013-10-01

Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

Completed

100 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00419042 2013-10-01

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Completed

100 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT01600807 2013-06-26

OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas

Phase 1/2 Withdrawn

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00440414 2010-08-19

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

Phase 3 Completed

320 enrolled